Atlas Trials

Investigate the Safety, Tolerability and Pharmacokinetics of FBL-MTX

Clinical trial NCT05117593 · COMPLETED

Trial details

NCT number
NCT05117593
Sponsor
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2021-06-28
Primary completion
2021-10-19
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.